Junde Pharmaceutical
Series A in 2025
Junde Medicine is a full-cycle innovator in chronic disease therapeutics. It helps in developing transformative drug-device combination products and new treatment methods by integrating materials science, pharmacy, biology, engineering, machine learning, and other multidisciplinary cutting-edge technologies to create innovative therapies for the full cycle of chronic diseases. The company focuses on unmet clinical needs for chronic diseases such as obesity, diabetes, mental illness, and metabolic-related fatty liver disease.
WestGene Biopharma
Series A in 2023
WestGene Biopharma is a high-tech enterprise specializing in the research, development, manufacturing, and sales of mRNA therapeutics and adjuvants. The company is focused on developing mRNA technology for the treatment of Epstein-Barr virus-related tumors and liver cancer, as well as for creating vaccines, including those for emerging infectious diseases. WestGene has patented innovations in two key areas: mRNA sequences and non-viral delivery vectors. Its work includes the development of 5'-UTR sequences using machine learning and the application of artificial intelligence to enhance the design of new lipid excipients. The company has established five mature technology platforms that support the research and development of various novel drug formulations, encompassing vaccines, gene editing, and antibodies.
EnCureGen Pharmaceuticals
Seed Round in 2023
Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.
Junde Pharmaceutical
Seed Round in 2023
Junde Medicine is a full-cycle innovator in chronic disease therapeutics. It helps in developing transformative drug-device combination products and new treatment methods by integrating materials science, pharmacy, biology, engineering, machine learning, and other multidisciplinary cutting-edge technologies to create innovative therapies for the full cycle of chronic diseases. The company focuses on unmet clinical needs for chronic diseases such as obesity, diabetes, mental illness, and metabolic-related fatty liver disease.
Huanzhi Technology
Venture Round in 2023
Huanzhi Technology specializes in developing intelligent supply chain management solutions. The company's primary focus areas include controlling unmanned industrial vehicles, deploying logistics robots, managing logistics control systems, and implementing industrial Internet of Things (IoT) applications. These technologies enable clients to achieve efficient and intelligent warehousing and logistics operations.
State Power Investment Corporation Limited (SPIC) is a major player in China's energy sector, formed in 2015 through the merger of China Power Investment Corporation and State Nuclear Power Technology Corporation. With a strong focus on clean energy, SPIC boasts a total installed capacity of 126 GW across various energy sources including thermal, hydropower, nuclear, solar, and wind power. Clean energy accounts for a significant portion of its capacity, reflecting its commitment to sustainable practices. Supplying a substantial amount of power and heat annually, SPIC also has coal production, aluminum smelting, and railway transportation capabilities in its portfolio. As one of China's top five power generators, SPIC is dedicated to driving the transformation of state-owned enterprises and setting high industry standards for the future.
Huizhou Yipeng Energy Technology Co.
Series C in 2022
Huizhou Yipeng Energy Technology Co., Ltd., founded in 2014 and based in Huizhou, China, specializes in the development, manufacturing, and marketing of lithium-ion battery systems for plug-in hybrid and pure electric vehicles. The company focuses on producing advanced battery solutions that cater to the growing demand for sustainable energy in the automotive industry. Through its innovative technology and commitment to quality, Yipeng Energy aims to contribute to the advancement of electric mobility.
Chengmandian Energy Technology
Series A in 2022
Chengmandian is a comprehensive provider of lithium battery energy solutions, specializing in the full life cycle management of lithium batteries. The company offers a range of services including charging, maintenance, leasing, replacement, and secondary utilization, emphasizing safe and efficient energy consumption. Chengmandian aims to innovate the application of lithium battery technology across various sectors such as shared motorcycles, battery swap systems, express delivery, and automotive industries. By focusing on digital operations and professional battery management, the company seeks to enhance energy recycling and operational efficiency, catering to both businesses and end consumers.
Dream Glass
Seed Round in 2022
Dream Glass is a company that specializes in the development of augmented reality glasses aimed at delivering portable and private virtual entertainment. Their product, Dreamworld, offers ultra-high-definition personal cinema and gaming experiences that can be accessed anytime and anywhere. The glasses are designed with plug-and-play technology, making them compatible with a variety of mobile platforms. By focusing on enhancing entertainment experiences, Dream Glass provides customers with innovative solutions for immersive viewing and interactive gaming.
Dream Glass
Seed Round in 2022
Dream Glass is a company that specializes in the development of augmented reality glasses aimed at delivering portable and private virtual entertainment. Their product, Dreamworld, offers ultra-high-definition personal cinema and gaming experiences that can be accessed anytime and anywhere. The glasses are designed with plug-and-play technology, making them compatible with a variety of mobile platforms. By focusing on enhancing entertainment experiences, Dream Glass provides customers with innovative solutions for immersive viewing and interactive gaming.
SolarSpace
Venture Round in 2022
SolarSpace is a manufacturer specializing in the development, production, and sales of high-efficiency solar cells and modules designed for solar infrastructure applications. The company boasts a production capacity of 35GW, with over 95% of its output consisting of large-size cells. SolarSpace focuses on providing the solar industry with reliable, sustainable, and efficient photovoltaic products, contributing to advancements in renewable energy solutions.
GAC Aion New Energy Automobile
Series A in 2022
GAC Aion New Energy Automobile is a Chinese manufacturer of electric vehicles, established in 2017 as a sub-brand of Guangzhou Automobile Corporation and officially launched as a marque in 2020. The company focuses on the development of new energy automobiles, aiming to deliver intelligent vehicles that enhance the driving experience for customers. GAC Aion emphasizes innovation and sustainability in its product offerings, contributing to the growing electric vehicle market in China.
Fourier is a semiconductor company. They design a complex structure digital-analog hybrid chip. They provide products that include car audio amplifiers, mid and high-power audio amplifiers, smart audio amplifiers, SPC audio amplifiers, haptic drivers, power management, and more.
Sunwoda Electric Vehicle Battery
Series A in 2022
Sunwoda Electric Vehicle Batter provides electric vehicle battery pack solutions for new energy vehicle companies through advanced lithium battery integration technology. They built the BMS with independent intellectual property rights by dedicating their entire ability to the R&D and manufacturing of electric car battery systems, and they also built up automatic production lines for cell sorting, modules, and battery packs.
Jiuling Lithium Industry
Venture Round in 2022
Jiuling Lithium Industry is a comprehensive lepidolite utilization service provider. Its main operations include product development, manufacturing, and sales of lithium salts.
CanSemi
Private Equity Round in 2022
CanSemi is a semiconductor manufacturing company based in China, specializing in the production of microprocessors, power management chips, analog chips, and power discrete devices. The company operates as an integrated device manufacturer (IDM), focusing on addressing the domestic demand for chips in various sectors, including the Internet of Things, automotive electronics, industrial control, and 5G technologies. By leveraging its manufacturing capabilities, CanSemi aims to support the growing needs of these advanced industries.
Changrong Electric
Private Equity Round in 2022
Changrong Electric is a company focused on the research, development, and manufacture of various electrical components, including motor sensor protectors, current sensors, motor controllers, drivers, and frequency inverters. It provides high-quality products and services to a range of industries, such as motors, household appliances, new energy, and automobiles. By prioritizing innovation and quality, Changrong Electric aims to meet the diverse needs of its clients across these sectors.
Chinagene Tech
Series A in 2022
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.
Gene Vector
Seed Round in 2022
Chengdu Genevector Biotechnology Co., Ltd. is a biotechnology firm specializing in the research and development of adeno-associated virus (AAV) gene therapy drugs. The company is dedicated to creating innovative therapies targeting a range of medical conditions, including ophthalmic diseases, neuromuscular disorders, hereditary diseases, cardiovascular and cerebrovascular diseases, as well as neurodegenerative diseases. Genevector aims to establish a comprehensive technology chain for AAV drug development, facilitating the delivery of novel biotherapy solutions to address significant health challenges.
Boshi Hi-tech
Series B in 2022
Boshi Hi-tech develops lithium-ion battery cathode materials for research, production and sales of lithium-ion battery cathode materials.
Cloudbreak Therapeutics
Series C in 2022
Cloudbreak Therapeutics LLC, established in 2015 and based in Irvine, California, is a biotechnology company specializing in the development of ocular drugs. It focuses on repurposing approved systemic drugs for eye delivery, aiming to treat glaucoma and pterygium diseases efficiently. The company operates a capital-efficient model, utilizing contract research organizations (CROs) to maximize resources for drug development. Its business strategy involves advancing drug candidates through proof-of-concept Phase II clinical trials and subsequently out-licensing global rights for Phase III trials, registration, and commercialization.
Chengmandian Energy Technology
Seed Round in 2021
Chengmandian is a comprehensive provider of lithium battery energy solutions, specializing in the full life cycle management of lithium batteries. The company offers a range of services including charging, maintenance, leasing, replacement, and secondary utilization, emphasizing safe and efficient energy consumption. Chengmandian aims to innovate the application of lithium battery technology across various sectors such as shared motorcycles, battery swap systems, express delivery, and automotive industries. By focusing on digital operations and professional battery management, the company seeks to enhance energy recycling and operational efficiency, catering to both businesses and end consumers.
Aoxion Technology
Series A in 2021
Aoxion Technology is a high-tech enterprise with core handwriting AI recognition technology, committed to providing full-scene digital solutions for judicial evidence for government, enterprise and public institutions. Based on the new generation of information technology such as big data, artificial intelligence, cloud computing, and blockchain, the company provides customers with a four-in-one full-stack signing service of "digital certificate and smart signing", which fully empowers paper documents electronically and electronically. Documents are digitized and data archives are evidenced to solve the last piece of paper in the digital society.
Shanghai Union Technology
Series D in 2021
Shanghai Union Technology is an additive manufacturing company that operates in the field of industrial 3D printing. UnionTech adds value to users and improves their experiences through 3D printing technology based on 3D digital manufacturing. The company improves actual production efficiency while reducing reliance on field production personnel and truly realizing refined production process management.
UnionTech 3D
Series D in 2021
UnionTech 3D specializes in stereolithography 3D printing, an additive manufacturing technology that enables the production of highly precise and detailed polymer parts. The company develops industrial-grade 3D printers tailored for various sectors, including manufacturing, automotive, aerospace, and medical industries. In addition to manufacturing equipment, UnionTech 3D emphasizes research and development to enhance its product offerings. The company also provides technical support to facilitate the integration of 3D printing into industrial production processes.
Greatpower
Series C in 2021
Greatpower Technology is a manufacturing facility specializing in nickel sulphate production, a key component for lithium-ion batteries used in electric vehicles. The company primarily engages in research and development of new energy resources and technologies, offering products such as ternary precursors and lithium battery cathode materials to facilitate battery recycling and contribute to the growth of the new energy power battery industry ecosystem.
Cospowers
Series B in 2021
Cospowers is a technology-driven company specializing in smart lithium battery solutions for a global clientele. Founded in 2003, the company focuses on the development and manufacturing of rechargeable batteries, chargers, and power battery packs. Cospowers employs advanced technology, scientific management methods, and enhanced detection techniques to ensure the safety and reliability of its products, which have received widespread acceptance among customers. In addition to its core battery offerings, the company provides comprehensive energy storage solutions, including systems for network energy, electric energy storage, and consumer applications, all aimed at promoting clean, efficient, and economical energy use.
Tonyshare Electronic Materials Technology
Venture Round in 2021
Tongxiang Technology is an enterprise that has been focusing on the research and development of tin-coated copper strips and electronic supporting products for solar photovoltaic modules and providing related services, and can develop various professional special welding strips, copper strips, and nickel strips according to customer requirements. , Aluminum strip, etc.
SolarSpace
Series A in 2021
SolarSpace is a manufacturer specializing in the development, production, and sales of high-efficiency solar cells and modules designed for solar infrastructure applications. The company boasts a production capacity of 35GW, with over 95% of its output consisting of large-size cells. SolarSpace focuses on providing the solar industry with reliable, sustainable, and efficient photovoltaic products, contributing to advancements in renewable energy solutions.
Laviana Pharma
Series C in 2021
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.
Bebetter Med
Private Equity Round in 2021
Bebetter Med is a pharmaceutical research and development company specializing in the creation of innovative small molecule oncology drugs. Its primary mission is to advance the treatment of cancer and other serious diseases through dedicated research and development efforts. The company is focused on developing and industrializing new drugs aimed at addressing major health challenges, positioning itself as a key player in the oncology sector.
Tage Zhixing
Series B in 2021
Beijing Tage Zhixing Technology Co., Ltd. is a high-tech enterprise focusing on mining vehicle unmanned driving technology research, product development, and overall engineering solution design and implementation of unmanned mines. Tage Zhixing has launched a car-ground-cloud collaborative smart mine unmanned transportation system, which realizes cloud intelligent dispatching management, 4G.
Genuine Biotech
Series B in 2021
Genuine Biotech manufactures drugs for the treatment of viral infection, tumors, and cerebrovascular disorders.
Abogen Biosciences
Series C in 2021
Abogen Biosciences, established in 2019 and headquartered in Jiangsu, China, specializes in the development of nucleic acid-based therapeutics, including RNA and DNA treatments, for combating cancer and infectious diseases.
Beijing Health Guard Biotechnology
Private Equity Round in 2021
Beijing Health Guard Biotechnology is a research and development firm based in Beijing, China, founded in 2008. The company focuses on the development of recombinant protein drugs and vaccines for the biotech industry. Its primary emphasis is on the research and industrialization of recombinant protein vaccines, particularly human papillomavirus (HPV) vaccines. Beijing Health Guard Biotechnology is advancing several innovative candidate vaccines targeting various infectious diseases, with its core pipeline featuring both trivalent and nonavalent HPV vaccines. The company employs a structure-guided design approach in its biopharmaceutical research and development efforts.
Berry Oncology
Series B in 2021
Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.
JOINN Biologics
Series B in 2021
JOINN Biologics is a California Bay Area-based company specializing in contract development and manufacturing services for biologics and advanced therapies. With over 20 years of experience in supporting drug discovery and development, JOINN offers a comprehensive range of services that includes molecular assessment, clinical trial material production, commercial-scale manufacturing, and both upstream and downstream process development. The company is dedicated to delivering high-quality biologics, aiming to enhance the efficiency of drug development while meeting the needs of patients and the biotech industry. By providing expertise in areas such as analytical and formulation development and regulatory support, JOINN Biologics plays a critical role in facilitating the advancement of biopharmaceutical products on a global scale.
Davinci Tech
Seed Round in 2021
Davinci Tech is committed to researching and developing robotic vehicles. Its primary products are the DC100, Dafenqi electric motorcycles, and pure electric heavy-duty motorcycles.
Ab&B Biotech
Series C in 2021
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
Dingdang Health Technology Group
Venture Round in 2021
Dingdang Health Technology Group provides accessible medical products and services to address various unmet health needs. It specializes in pioneering online-to-offline solution-led real-time drug retail and medical consultation.
Dingdang Kuaiyao
Private Equity Round in 2021
Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform. After users place orders on the mobile app, drugs will be delivered to their homes within half an hour.
Simcere Pharma
Series B in 2021
Simcere Pharmaceutical Group is a prominent manufacturer and distributor of pharmaceuticals based in Nanjing, China, founded in 1995. The company has transitioned from a distributor to a leading player in China's pharmaceutical market, operating five GMP-certified manufacturing facilities and maintaining a strong workforce of over 4,000 employees. Simcere's product portfolio encompasses a wide range of medications targeting various therapeutic areas, including oncology, nervous system diseases, autoimmune disorders, and infections. Notable products include recombinant human endostatin injection for lung cancer, edaravone for acute cerebral infarction, and various formulations of amoxicillin for infections. The company also develops treatments for conditions such as arthritis, diarrhea, and cardiovascular diseases. Simcere has established strategic partnerships with organizations like Bristol-Myers Squibb and Jiangsu Alphamab Biopharmaceuticals to enhance its research and development capabilities.
KUNSHAN TOPA INTELLIGENT EQUIPMENT
Post in 2021
Kunshan Topa Intelligent Equipment manufactures electronics and equipment. Their products include fuse box assembly lines, straight return conveyor lines, ECU assembly lines, and synchronous belt loop conveying lines. They provide products and sales services for the consumer electronics and transportation industry.
Aichong Biotech
Private Equity Round in 2021
Aichong Biotech is a pet biopharmaceutical company that offers product pipeline and technology content. It specializes in the production of veterinary vaccines, particularly rabies vaccines for pets, as well as other animal health products. Aichong Biotech is primarily involved in the research, development, and production of veterinary vaccines and other animal health products.
Hrain Biotechnology
Series C in 2021
Hrain Biotechnology is a developer of tumor immunotherapy technologies focused on delivering precise treatments for cancer patients. The company employs Chimeric Antigen Receptor T-cell (CAR-T) technology to enhance the effectiveness of cancer therapies. By establishing clinical trial platforms in various locations, including Beijing, Jiangsu, Chongqing, and Henan, Hrain Biotechnology facilitates the development and implementation of innovative medical treatments in clinical settings. Through its research and technology, the company aims to improve patient outcomes by enabling hospitals and clinics to offer advanced therapeutic solutions tailored to individual needs.
Pinpianyi
Series C in 2021
Pinpianyi is a Hangzhou-based start-up focused on creating a smart procurement platform tailored for convenience stores. The company's innovative platform leverages artificial intelligence technology to offer product price data analysis and intelligent ordering services, which assist retailers in optimizing their procurement processes. By facilitating connections between over 10,000 offline stores and more than 1,000 suppliers, Pinpianyi aims to minimize procurement and logistics costs, enhance capital turnover efficiency, and reduce inventory backlog for its clients. Through its advanced technological solutions, the company seeks to streamline operations within the convenience store sector and support sustainable growth.
Beixin New Energy Technology
Series A in 2021
Beixin is a technology company, dedicated to providing first-class solutions and services for global new energy applications. Founded in 1999, the company is based in Qidong, China.
Ark Biosciences
Series C in 2021
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of therapeutics aimed at addressing unmet medical needs, particularly in the areas of respiratory viral infections and viral hepatitis. Founded in 2013, the company focuses on developing innovative treatments, including AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences is committed to advancing antiviral drug research and development to serve both global and Chinese markets.
SMEC
Venture Round in 2021
SMEC provides foundry services focusing on technology solutions for power, connection, and sensor signal chain.
MaxPhotonics
Venture Round in 2021
MaxPhotonics is a developer and manufacturer of advanced laser technology, specializing in a range of laser devices, including pulsed, continuous wave (CW), quasi-continuous wave (QCW) fiber lasers, diode lasers, and laser cleaning machines. The company has secured 448 patents and 23 copyrights for its innovations and has achieved independent production of essential optical components such as pump sources, combiners, and isolators. These products find diverse applications in industries such as marking, engraving, cutting, welding, and additive manufacturing. MaxPhotonics aims to change industry standards by pursuing vertical integration of fiber lasers and optical devices, supported by a global sales and service network that spans Asia, Europe, America, and Oceania.
Microread
Series C in 2020
Microread is a commercialization company that focuses on sequencing technology platforms for genetic detection. They refined production processes and quality verification, and they developed a series of economical test reagents for forensic, clinical, agricultural, animal husbandry, and research fields.
Siflower Communication
Private Equity Round in 2020
Siflower Communication is a Shanghai-based company specializing in the development of wireless WiFi communication chips and solutions tailored for Internet of Things (IoT) infrastructure. Founded in 2014, the company focuses on creating integrated circuit chips for WiFi wireless routers, which are utilized in devices such as home gateways, repeaters, and smart home systems. Siflower Communication aims to enhance the efficiency and reliability of WiFi technology, offering faster connection speeds and improved performance in various applications, including satellite navigation. The company's commitment is to foster a safe and intelligent home environment through advanced communication solutions.
MicuRx Pharmaceuticals
Series E in 2020
MicuRx Pharmaceuticals is a biopharmaceutical company focused on discovering and developing novel antibiotics to combat drug-resistant bacterial infections. Founded in 2007 and based in Palo Alto, California, MicuRx operates with research and development facilities in both San Francisco, California, and Shanghai, China. The company's portfolio includes MRX-I, an oral antibiotic effective against multi-drug resistant gram-positive pathogens such as methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci; MRX-IV, a water-soluble prodrug form of MRX-I for intravenous use; MRX-V, an injectable antibiotic targeting gram-negative bacteria; and MRX-VIII, a polymyxin for gram-negative infections. Additionally, MicuRx's pipeline includes other antibacterial drugs designed to combat both gram-positive and gram-negative bacterial pathogens. The company employs a hybrid U.S./China business model, leveraging U.S. research and development with cost-efficient scientific resources in China. Shanghai MicuRx commercializes the agent contezolid in China, while global clinical studies are ongoing.
Denovo Biopharma
Series D in 2020
Denovo Biopharma (Hangzhou) Co. Ltd, based in Hangzhou, China, is a privately held biotechnology company specializing in biopharmaceuticals. The company focuses on personalized drug development through a unique platform that enables de novo genomic biomarker discovery using archived clinical samples. This innovative technology is particularly beneficial for late-stage clinical drugs that have previously demonstrated unsatisfactory efficacy. By identifying biomarkers linked to patient responsiveness, Denovo Biopharma assists biotech and pharmaceutical companies in designing targeted clinical trials, which aim to enhance efficacy and reduce adverse effects. Their biomarker discovery capabilities extend across various therapeutic areas, including oncology, metabolic disorders, cardiology, immunology, and neurology.
PegBio
Private Equity Round in 2020
PegBio Co., Ltd., established in 2008 and headquartered in Suzhou, China, is a biopharmaceutical company specializing in the development and manufacturing of polyethylene glycol (PEG) and PEGylation technology. The company offers a range of PEG synthesis technologies, including N-terminal specific, thiol-selective, and enzymatic PEGylation, as well as pharmaceutical-grade PEGs for biopharmaceutical applications. PegBio also provides reagent-grade mPEGs with varying molecular weights, structures, and activation groups, catering to both domestic and international customers in academia and the pharmaceutical industry. Additionally, the company offers PEGylation services for chemical modifications of macromolecules and develops PEGylated products, such as PB-119, an agonist of glucagon-like peptide 1 (GLP-1) for treating type 2 diabetes. PegBio's PEGylation technology is employed to modify proteins, peptides, antibody fragments, oligonucleotides, and small molecules, serving universities, research institutes, and pharmaceutical companies.
TongFu Microelectronics
Post in 2020
Tongfu Microelectronics Co., Ltd is a prominent player in the semiconductor industry, specializing in integrated circuit (IC) assembly and testing services. Established in 1997 and headquartered in Nantong, China, the company offers a diverse range of packaging solutions, including wafer-level, flip chip, ball grid array, and various plastic packaging types. Its products cater to numerous applications, including wireless communications, power management, memory, microprocessors, and automotive devices. Tongfu Microelectronics also provides comprehensive support through test platforms and engineering services for analog, mixed-signal, and digital semiconductor devices. The company's focus on meeting the demands of system manufacturers and its alignment with national industrial policies underscore its role in the coordinated development of the semiconductor supply chain. Formerly known as Nantong Fujitsu Microelectronics Co., Ltd, the company rebranded in December 2016 to reflect its growth and commitment to innovation in the semiconductor market.
Ark Biosciences
Venture Round in 2020
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of therapeutics aimed at addressing unmet medical needs, particularly in the areas of respiratory viral infections and viral hepatitis. Founded in 2013, the company focuses on developing innovative treatments, including AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences is committed to advancing antiviral drug research and development to serve both global and Chinese markets.
Qihe Biotech
Venture Round in 2020
Qihe Biotech is a manufacturer based in Zibo, China, specializing in the research and development, production, and export of edible fungi. The company focuses on creating high-quality edible fungus products and aims to serve diverse markets across various countries. In addition to its product offerings, Qihe Biotech provides technical guidance services to customers in different regions, enhancing their ability to meet local market demands. Through its commitment to innovation and quality, the company seeks to establish a strong presence in the global edible fungi industry.
WM Motor Technology Co., Ltd., founded in 2015 and based in Shanghai, China, specializes in the design, development, and manufacture of electric vehicles. The company focuses on creating energy-efficient and battery-operated vehicles, offering innovative travel solutions to its customers. WM Motor emphasizes the integration of advanced technologies in its products, featuring the Living Motion electric powertrain, Living Pilot intelligent driving assistance system, and Living Engine operating system. These technologies provide enhanced connectivity and interactive capabilities, contributing to the efficiency and intelligence of its smart vehicle offerings.
Adlai Nortye
Series C in 2020
Adlai Nortye Biopharma Co., Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China, specializing in the research and development of innovative oncology therapies. Founded in 2004 and formerly known as Sinopep Pharmaceutical Inc., the company focuses on developing cancer treatments and addressing metabolic diseases. Adlai Nortye operates R&D and clinical operation centers in both China and the United States, emphasizing its global approach to drug development. The company has established a robust pipeline featuring over ten drug candidates, including those in various stages of clinical and preclinical development, such as buparlisib, palupiprant, and AN4005. Through collaborations and internal discoveries, Adlai Nortye seeks to advance its goal of providing effective treatment options for patients with a wide range of tumor types.
Robint
Venture Round in 2020
Beijing Robint Technology Co. Ltd. is a technology hardware company based in Beijing, China, specializing in the research, development, design, production, and sale of artificial intelligence robots. The company offers a range of products, including intelligent service robots, delivery robots, distribution containers, and food delivery robots. Robint focuses on developing patented core technologies in areas such as precise perception, intelligent identification, human-like cognition, collaborative decision-making, and high-precision mapping and motion control, positioning itself as a significant player in the AI robotics sector.
Hanyu Medical
Series D in 2020
Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices. Specializing in minimally invasive treatments for mitral valve regurgitation, the company’s flagship product is the Valve Clamp, an interventional device designed to assist in the closure of heart valves during surgical procedures. By focusing on innovative solutions for heart valve diseases, Hanyu Medical aims to enhance surgical outcomes and patient recovery through its advanced medical technologies.
Haihe Biopharma
Series B in 2020
Haihe Biopharma is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors. Through its research and development efforts, Haihe Biopharma seeks to enhance health outcomes and the quality of research for its customers, providing effective solutions in the fight against cancer.
COSMX
Private Equity Round in 2020
COSMX, also known as Zhuhai Cosmx Battery Co Ltd, specializes in the research, development, production, and sales of consumer polymer soft-pack lithium-ion batteries. The company serves a diverse range of markets, including notebook computers, tablet computers, smartphones, smart wearables, power tools, and drones. By focusing on innovative battery technology, COSMX aims to meet the evolving needs of its customers in various high-demand sectors.
LaNova Medicines
Series A in 2020
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Asieris Pharmaceuticals
Series C in 2020
Asieris Pharmaceuticals Co. Ltd. is a biotechnology company based in Taizhou, China, founded in 2010. The company is dedicated to the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. By focusing on oncology and infectious diseases, Asieris Pharmaceuticals seeks to develop innovative therapies that meet the medical needs of patients both in China and globally.
LaNova Medicines
Seed Round in 2020
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
EOC Pharma Group
Series C in 2019
EOC Pharma Group is a biopharmaceutical company based in Shanghai, China, founded in 2015. It specializes in the development, manufacturing, and commercialization of innovative oncology products. EOC employs a licensing model to enhance its product pipeline by incorporating molecules from global biopharmaceutical partners into its robust local infrastructure, which includes manufacturing, clinical development, regulatory filing, and commercialization. The company has a diverse pipeline featuring seven novel products, several of which are positioned as potentially first- and best-in-class. EOC has achieved regulatory milestones with four Class I innovative drug approvals and has initiated clinical studies for its leading products. The company operates an 8,000 square meter cGMP manufacturing facility in Taizhou and maintains offices in key locations, including Shanghai, Beijing, Hong Kong, and Los Angeles. With a team of experienced professionals, EOC aims to establish itself as a leader in oncology innovation in China through strategic partnerships and a comprehensive integrated platform.
THOK LOGISTICS
Venture Round in 2019
THOK LOGISTICS provides solution services for supply chain logistics integrating consulting planning, system integration, logistics technology equipment product manufacturing, and software system research and development. It is a supply chain logistics solution provider.
Phylion Battery
Private Equity Round in 2019
Phylion Battery is a manufacturer based in Suzhou, China, specializing in the development, production, and sales of lithium-ion batteries. Utilizing lithium manganate as its positive electrode material, the company has established an annual production capacity of 5GWh. With over 15 years of experience in technology transformation, Phylion has successfully served 8 million end users and provided battery solutions for more than 45,000 electric vehicles globally. The company is recognized as a high-tech enterprise in the power lithium battery sector and is actively involved in research and development within the energy storage field. Phylion is committed to delivering innovative power supply solutions for new energy vehicles and various industrial applications worldwide.
Voc Acoustic Technology
Series A in 2019
Hunan Voc Acoustic Technology Co., Ltd. is a Chinese company specializing in the development, manufacture, and sale of acoustic products, including headphones, Bluetooth earphones, high-fidelity audio devices, and smart speakers. Founded in 2017 and based in Zhuzhou, the company engages in comprehensive acoustic technology services, integrating research and development with production and sales. Voc Acoustic Technology has entered the true wireless stereo (TWS) headset market and offers acoustic research and production services to brands globally, catering to both domestic and international clients.
Haihe Biopharma
Series B in 2019
Haihe Biopharma is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors. Through its research and development efforts, Haihe Biopharma seeks to enhance health outcomes and the quality of research for its customers, providing effective solutions in the fight against cancer.
Heng Yi Biotechnology
Venture Round in 2019
Heng Yi Biotechnology Co., Ltd., established in 1974 and based in Taichung, Taiwan, specializes in the manufacture of nutritional and dietary supplements using natural ingredients and high-quality raw materials. The company's product portfolio includes food ingredients, essential oils, fragrances, beverages, confectionery items, organic products, healthcare items made from plants, probiotics, and fiber, pharmaceutical ingredients, and spray-dried powder. Additionally, Heng Yi Biotechnology is involved in the import and export of food raw materials both domestically and internationally. The company is committed to delivering high-quality products at competitive prices through innovative formulations and stringent quality control measures throughout the manufacturing, storage, distribution, and sales processes.
Hanyu Medical
Series B in 2018
Hanyu Medical is a pioneering company in the development, production, and sale of transcatheter mitral valve repair devices. Specializing in minimally invasive treatments for mitral valve regurgitation, the company’s flagship product is the Valve Clamp, an interventional device designed to assist in the closure of heart valves during surgical procedures. By focusing on innovative solutions for heart valve diseases, Hanyu Medical aims to enhance surgical outcomes and patient recovery through its advanced medical technologies.
Chunmi Technology, founded in 2013 and headquartered in Shanghai, China, specializes in the development and manufacturing of smart kitchen appliances. The company offers a diverse range of products, including rice cookers, ovens, and microwaves, all designed to enhance the cooking experience through the Internet of Things (IoT). Chunmi's appliances are equipped with software and hardware systems that connect to a mobile application, allowing consumers to monitor and control their cooking processes remotely. This integration of technology into everyday kitchen tasks positions Chunmi as a leader in the smart kitchen appliance market.
Royole Corporation is a leading manufacturer of advanced flexible displays, flexible sensors, and smart devices, headquartered in Fremont, California, with an additional office in Shenzhen, China. Established in 2012, the company specializes in innovative products such as foldable smartphones, tablets, smart writing pads, and mobile theaters. Its offerings include the FlexPai smartphone, flexible wearables, RoWrite smart writing pad, and Moon three-dimensional mobile theater. Royole's technology serves various industries, including consumer electronics, automotive, computing, and telecommunications, enabling tailored solutions for applications in smart mobile devices, transportation, media, entertainment, and education. The company emphasizes both design and production, and it also provides consulting services to its clients. Royole maintains a strategic partnership with JD.COM to enhance its product distribution online.
Huizhou Yipeng Energy Technology Co.
Corporate Round in 2018
Huizhou Yipeng Energy Technology Co., Ltd., founded in 2014 and based in Huizhou, China, specializes in the development, manufacturing, and marketing of lithium-ion battery systems for plug-in hybrid and pure electric vehicles. The company focuses on producing advanced battery solutions that cater to the growing demand for sustainable energy in the automotive industry. Through its innovative technology and commitment to quality, Yipeng Energy aims to contribute to the advancement of electric mobility.
Health Engine
Corporate Round in 2018
Health Medical Technology is engaged in the intelligent management of medical equipment. They provide internet of things tools such as the self-developed equipment asset management platform and remote equipment management system, which realize the dynamics of intelligentization and dataization of the entire life cycle of medical equipment. They improve the efficiency of equipment operation, and realize the refined management of medical equipment through the mining and application of big data in medical equipment management.
Kanghua Biotechnology
Angel Round in 2018
Kanghua Biotechnology is a manufacturer based in Weifang, China, specializing in the development of biochemical reagents and in vitro diagnostic (IVD) products. Established in 1996, the company produces a wide range of diagnostic tools, including rapid test kits for fertility, hepatitis, infectious diseases, and tumor markers, as well as ELISA kits for blood screening and other medical assessments. Their offerings cater to diverse areas such as prenatal and postnatal care, respiratory and digestive tract diagnostics, and rheumatic diseases. Kanghua Biotechnology is committed to providing medical facilities with reliable diagnostic supplies and equipment, supporting accurate disease diagnosis and patient care.
Chengdu Kanghua Biological Products
Private Equity Round in 2018
Kanghua Biological is a research and development, production, and operation of preventive biological products. The company's research and development, production base, SPF laboratory animal center, and high-tech bacterial and virus vaccine GMP production workshop occupy 30,000 square meters. Its existing product includes ACYW135 group Meningococcal Polysaccharide Vaccine, (trade name: Maicred) and Freeze-dried Rabies Vaccine for Human Use (Human Diploid Cells), (trade name: HDCV). It has been awarded the titles of "Postdoctoral Innovation Practice Base", "Sichuan Province Constructive Innovation Enterprise Cultivation Enterprise", "Sichuan Province Excellent Integrity Demonstration Unit" by the Personnel Department and the Science and Technology Department. It was founded in 2004 in Chengdu, Sichuan, China.
LEADTHING is a software and information technology service company. They provide corresponding software products and solutions for customer information. Their products cover institutions, military, public security, and border defense.
JHOME is an import and export rights company and an Internet B2C sales platform for drugs and medical devices. Their production and sales of in vitro diagnostic reagents and instruments, medical imaging, and medical electronic equipment. They focus on product and technological innovation in the fields of medical care, family health, and public safety.
JAKI product research and development, and promotes development. They provides delivery services like .211 limited time, delivery service inquiry, shipping fee charging standard and overseas delivery. They also provides online education for the kids.
34learning
Seed Round in 2018
34learning provides products and services such as digital learning solutions, micro-consulting projects, mixed project courses, and traditional courses. They also offer online learning development solutions for their partners. Their courses include mixed learning, leadership development, professional development, personal ability development, and others.
Goldpro
Corporate Round in 2017
Goldpro is one professional manufacturer and exporter of grinding media steel balls in China. Besides supplying different sizes of grinding steel balls, the company also provides other services, like developing new special steel balls according to the ore conditions for its customers.
11ziyun.com is a printing paper company. Their service platform spans e-commerce, logistics, cloud computing, big data, and cross border transaction services. They offer advertising materials, commercial printing, digital printing materials, design services, office supplies, student supplies, and paper pulps.
LC Securities
Series B in 2017
LC Securities is an integrated financial services platform in Guangdong. The company provides credit business, fixed income, and asset management services. The business focuses on offering Chinese high-net-worth individuals professional, effective, and convenient one-stop financing services.
Yondervision is a technology company based in Beijing that specializes in providing digital solutions for housing provident funds and financial services. The company offers a wide range of services, including customized software development, maintenance, and integration for housing provident fund management agencies and banks. Yondervision operates across five main sectors: digital provident fund, digital port, digital financial services, service outsourcing, and data intelligence services. In addition, the firm provides statistical reports and modeling tools for data analysis, enhancing decision-making capabilities for its clients in the housing finance sector. Through its comprehensive suite of offerings, Yondervision aims to support and improve the efficiency of housing provident fund operations nationwide.
Shanghai Sanyou Medical
Private Equity Round in 2017
Shanghai Sanyou Medical Co., Ltd., based in Shanghai, specializes in the research, development, manufacturing, and sales of orthopedic implants in China. The company offers a range of products under the Tytus and Sanyou brands, including spinal implants like anterior cervical plates, posterior thoracolumbar systems, and minimally invasive products, as well as trauma implants for shoulders, elbows, hips, knees, and wrists. Established in 2010, the company is committed to independent innovation and has a senior international management team.
KUNSHAN TOPA INTELLIGENT EQUIPMENT
Venture Round in 2017
Kunshan Topa Intelligent Equipment manufactures electronics and equipment. Their products include fuse box assembly lines, straight return conveyor lines, ECU assembly lines, and synchronous belt loop conveying lines. They provide products and sales services for the consumer electronics and transportation industry.
Bright Key
Series A in 2017
Bright Key provides SAP services. They also provide consulting, implementation, operation, and maintenance services of SAP software products, including implementation services of various application modules of the SAP ERP system, enterprise SAP ERP system before receiving external audit consulting services, daily operation and maintenance, technical support, and tuning services of SAP ABAP and SAP Java programs, and more.
SMO ClinPlus
Venture Round in 2016
SMO ClinPlus Co., Ltd. is a Shanghai-based company that specializes in providing clinical trial and site management organization (SMO) services. Founded in 2009 and formerly known as Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd., the company rebranded in November 2016. SMO ClinPlus serves both domestic and international pharmaceutical and medical device companies, as well as entities involved in clinical research and the development of health-related products. Their range of services includes the establishment of preliminary models, preparation of initial plans, initiation of clinical trial sites, on-site implementation, and comprehensive project management, all aimed at facilitating efficient and effective clinical trial processes.
Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the innovation, research, development, manufacture, and sales of new medications. The company aims to establish itself as a leader in the Chinese biopharmaceutical industry, focusing on treatments for cancer, hematologic diseases, and other significant health challenges. Zelgen's business strategy emphasizes addressing unmet medical needs within the domestic market by developing high-quality, safe, effective, and affordable medications. The company's research and development efforts encompass new chemical and biological drugs across various therapeutic areas, including tumors and liver-related diseases.
SMO ClinPlus
Venture Round in 2016
SMO ClinPlus Co., Ltd. is a Shanghai-based company that specializes in providing clinical trial and site management organization (SMO) services. Founded in 2009 and formerly known as Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd., the company rebranded in November 2016. SMO ClinPlus serves both domestic and international pharmaceutical and medical device companies, as well as entities involved in clinical research and the development of health-related products. Their range of services includes the establishment of preliminary models, preparation of initial plans, initiation of clinical trial sites, on-site implementation, and comprehensive project management, all aimed at facilitating efficient and effective clinical trial processes.